NVSEF - TG Therapeutics upgraded at Goldman Sachs after selloff
2023-08-02 08:56:23 ET
More on TG Therapeutics
- TG Therapeutics: The Hype Is Gone
- TG Therapeutics: Fairly Valued After Earnings Miss, EU Deal (Rating Upgrade)
- TG Therapeutics: Addressing The SC Ocrevus Concern
- TG Therapeutics falls as Roche succeeds in Phase 3 trial for multiple sclerosis therapy
- Seeking Alpha’s Quant Rating on TG Therapeutics
- Earnings data for TG Therapeutics
For further details see:
TG Therapeutics upgraded at Goldman Sachs after selloff